Christina Lopes, the CEO and cofounder of The One Health Company, explained at the World Economic Forum in Davos that her company seeks to use pet dogs and cats suffering from the kinds of conditions that pharmaceutical companies are developing treatments for in humans (such as bone cancer, lymphoma) for animal trials as part of drug development. The rationale is that the canine genome more closely resembles humans than the mouse genome. And pharma companies can use the data for R&D.